Impact of the COVID-19 pandemic on cancer healthcare utilization in southwestern China on March 2021.
Peiyi LiYajuan ZhuYaqiang WangXiaoyu LiuXiang FangYuanxin HouRujun ZhengJunying LiBo ZhangZhuo ChenChengdi WangTao ZhuWei-Min LiXuesong HanPublished in: Cancer medicine (2023)
As of March 2021, despite few COVID-19 cases, the COVID-19 pandemic has had a strong and continuing impact on in-person oncology care utilization in southwestern China under the Dynamic Zero-COVID Strategy. Equitable and timely access to cancer care requires adjustment in strict policies for COVID-19 prevention and control, as well as targeted remedies for the most vulnerable populations during and beyond the pandemic. Future studies should monitor the long-term effects of the COVID-19 pandemic and response strategies on cancer care and outcomes.